AP02

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPFNCT07194382AVLNPhase 2Recruiting2026-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.